Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses

Valérie Gounant,Valentine Marie Ferré,Ghassen Soussi,Charlotte Charpentier,Héloïse Flament,Nadhira Fidouh,Gilles Collin,Céline Namour,Sandra Assoun,Alexandra Bizot,Zohra Brouk,Eric Vicaut,Luis Teixeira,Diane Descamps,Gérard Zalcman

Journal of Thoracic Oncology（2022）

引用 54|浏览34

暂无评分

摘要

SARS-CoV2 vaccines were shown to be efficient in thoracic cancer patients, most of them being immunized after two doses. A third shot given to 1% of patients with persistent low antibody titers resulted in a 88% immunization rate.

查看译文

关键词

Lung cancer,COVID-19,SARS-CoV-2,mRNA vaccine,Antibody response

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要